Maze Therapeutics, Inc.
MAZE
DELAYED 1 MONTH
23 insider filings · Latest: Jul 29, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | Jul 31 8:15 PM | Atul DandekarCSBO | Sale | 7,500 | $27.34 | $205.0K | 26,250(D) | View → |
| Jun 1, 2026 | Jun 3 9:04 PM | Jason V ColomaDirector, Chief Executive Officer | Sale | 6,643 | $26.20 | $174.0K | 27,970(I) | View → |
| Jun 1, 2026 | Jun 3 9:01 PM | Harold BernsteinPresident, R&D & CMO | Sale | 14,853 | $25.66 | $381.1K | 0(D) | View → |
| May 29, 2026 | Jun 2 8:12 PM | Atul DandekarCSBO | Sale | 7,500 | $26.34 | $197.6K | 24,808(D) | View → |
| May 26, 2026 | May 27 8:16 PM | Jason V ColomaDirector, Chief Executive Officer | Sale | 25,582 | $26.02 | $665.5K | 350,987(I) | View → |
| May 22, 2026 | May 27 8:16 PM | Jason V ColomaDirector, Chief Executive Officer | Sale | 6,982 | $26.00 | $181.5K | 28,523(I) | View → |
| May 15, 2026 | May 18 9:07 PM | Jason V ColomaDirector, Chief Executive Officer | Sale | 1,938 | $26.00 | $50.4K | 31,001(I) | View → |
| May 14, 2026 | May 18 9:03 PM | Harold BernsteinPresident, R&D & CMO | Sale | 15,000 | $26.22 | $393.4K | 0(D) | View → |
| Apr 29, 2026 | May 1 8:18 PM | Atul DandekarCSBO | Sale | 7,500 | $25.37 | $190.3K | 10,503(D) | View → |
| Mar 10, 2026 | Mar 12 8:51 PM | Harold BernsteinPresident, R&D & CMO | Sale | 30,000 | $50.45 | $1.5M | 0(D) | View → |
| Feb 27, 2026 | Mar 3 9:25 PM | Atul DandekarCSBO | Sale | 7,500 | $45.43 | $340.7K | 10,503(D) | View → |
| Mar 2, 2026 | Mar 3 9:20 PM | Amy BachrodtSVP, Finance | Sale | 5,000 | $45.20 | $226.0K | 12,965(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 3 9:17 PM | Jason V ColomaDirector, Chief Executive Officer | Grant/Award | 225,000 | $45.61 | 75,000(D) | View → |
← Previous
Page 2 of 2